Have a personal or library account? Click to login
Can a Presepsin (Scd14-St) Obtained from Tracheal Aspirate Be a Biomarker for Early- Onset Neonatal Sepsis Cover

Can a Presepsin (Scd14-St) Obtained from Tracheal Aspirate Be a Biomarker for Early- Onset Neonatal Sepsis

Open Access
|Dec 2020

References

  1. 1. Raymond SL, Stortz JA, Mira JC, Larson SD, Wynn JL, Moldawer LL. Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches. Front Pediatr 2017;5(14);DOI:10.3389/fped.2017.00014.10.3389/fped.2017.00014529381528224121
  2. 2. Mukhopadhyay S, Puopolo KM. Risk Assessment in Neonatal Early-Onset Sepsis. Seminars in perinatology. 2012;36(6):408-15; DOI:10.1053/j.semperi.2012.06.00210.1053/j.semperi.2012.06.002378230223177799
  3. 3. Liu B, Chen Y.X., Yin Q, Zhao Y.Z., Li C.S. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Critical Care 2013, 17:R244;DOI:10.1186/cc13070.10.1186/cc13070405632224138799
  4. 4. Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J et al. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Critical Care 2014,18:R19;DOI:10.1186/cc13700.10.1186/cc13700405742424443891
  5. 5. Spanuth E, Ebelt H, Ivandic B, Werdan K. Diagnostic and prognostic value of presepsin (soluble CD14 sub-type) in emergency patients with early sepsis using the new assay PATHFAST Presepsin. 21st International Congress of Clinical Chemistry and Laboratory Medicine, IFCC-WorldLab – EuroMedLab, Berlin, 15-19 May 2011. Poster 0333.10.1515/9783110224641.128
  6. 6. Wu J, Hu L, Zhang G, Wu F, He T. Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis. PLoS ONE 10(7):e0133057.DOI: 10.1371/journal.pone.0133057.10.1371/journal.pone.0133057450799126192602
  7. 7. Faix JD. Presepsin — The new kid on the sepsis block. Clin Biochem. 2014 May;47(7-8):503-4;DOI:10.1016/j.
  8. 8. Montaldo P, Rosso R, Santantonio A, Chello G, Giliberti P. Presepsin for the detection of early-onset sepsis in preterm newborns.. Pediatr Res. 2017 Feb;81(2):329-34;DOI:10.1038/pr.2016.217.10.1038/pr.2016.21727925621
  9. 9. Savić D, Simović A, Marković S, Kostić G, Vuletić B, Radivojević S, Lišanin M, Igrutinović Z, Pavlović R. The Role of Presepsin Obtained from Tracheal Aspirates in the Diagnosis of Early Onset Pneumonia in Intubated Newborns. Indian J Pediatr. 2018 Apr 14;DOI:10.1007/s12098-018-2676-2. [Epub ahead of print]10.1007/s12098-018-2676-229654571
  10. 10. Pugni L, Pietrasanta C, Milani S, Vener C, Ronchi A, Falbo M et al. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates. PLoS One 2015;10(12):e0146020;D OI:10.1371.10.1371/journal.pone.0146020469779426720209
  11. 11. Topcuoglu S, Arslanbuga C, Gursoy T, Aktas A, Karatekin G, Uluhan R, Ovali F. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med. 2016;29(11):1834-9;DOI:10.3109/14767058.
  12. 12. Stubljar D, Kopitar AN, Groselj-Grenc M, Suhadolc K, Fabjan T, Skvarc M. Diagnostic Accuracy of Presepsin (sCD14-ST) for Prediction of Bacterial Infection in Cerebrospinal Fluid Samples from Children with Suspected Bacterial Meningitis or Ventriculitis. J Clin Microbiol 2015;53(4):1239-44;DOI: 10.1128/JCM.03052-14.10.1128/JCM.03052-14436520625653398
  13. 13. Sansano S, Fearns C, Ulevitch R, Zimmerli W, Land-mann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol 1999;162:4762–72.10.4049/jimmunol.162.8.4762
  14. 14. Lin B, Noring R, Steere AC, Klempner MS, Hu LT. Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease. J Infect Dis 2000;181(3):1185-8;DOI:10.1086/315357.10.1086/31535710720552
  15. 15. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011;17(6):764-9;DOI:10.1007/s10156-011-0254-x.10.1007/s10156-011-0254-x21560033
  16. 16. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18(6):891-7;DOI:10.1007/s10156-012-0435-2.10.1007/s10156-012-0435-222692596
  17. 17. Janota J, Stranák Z, Bĕlohlávková S, Mudra K, Simák J. Post-natal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Eur J Clin Invest. 2001 Nov; 31(11):978-83;DOI:org/10.1046/j.1365-2362.2001.00912.x10.1046/j.1365-2362.2001.00912.x11737240
  18. 18. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-Onset Neonatal Sepsis. Clinical Microbiology Reviews 2014;27(1):21-47; DOI:10.1128/CMR.00031-13.10.1128/CMR.00031-13391090424396135
  19. 19. Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Ge-bert S, Winter J et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009;47(9):2759-65.;DOI: 10.1128/JCM.00567-09.10.1128/JCM.00567-09273807919571030
  20. 20. Adib M, Bakhshiani Z, Navaei F, Saheb Fosoul F, Fouladi S, Kazemzadeh H. Procalcitonin: A Reliable Marker for the Diagnosis of Neonatal Sepsis. Iranian Journal of Basic Medical Sciences. 2012;15(2):777-782.
DOI: https://doi.org/10.2478/sjecr-2018-0021 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 225 - 230
Submitted on: May 16, 2018
Accepted on: Jul 11, 2018
Published on: Dec 21, 2020
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Dragana Savic, Aleksandra Simovic, Radiša Pavlovic, Sanja Knezevic, Nevena Folic, Bojana Trikos, Zorana Djordjevic, Zoran Igrutinovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.